Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Worldwide Clinical Trials??? Experts To Advance Discussion On Innovative Strategies For Translational Research Services August 13, 2017 Syndax To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call And Webcast On March 2, 2017 February 15, 2017 Sarepta Taps Allergan Alum as New CEO June 28, 2017
Worldwide Clinical Trials??? Experts To Advance Discussion On Innovative Strategies For Translational Research Services August 13, 2017
Syndax To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call And Webcast On March 2, 2017 February 15, 2017